Overview LSAC Graphical Patient Pro les (GPP)...SOLUTIO RIF LSAC Graphical Patient Pro les (GPP)...

3
SOLUTION BRIEF LSAC Graphical Patient Profiles (GPP) Overview Patient safety is a primary focus of medical monitoring during clinical trials. Understanding the scientific and medical parameters relevant to each patient, however, can be challenging when multiple software systems and stakeholders are involved. Saama’s Clinical Insights application, part of the Life Science Analytics Cloud (LSAC), offers a streamlined solution for medical teams that need to stay on top of all safety data requirements. GPP’s Role in Facilitating Patient Safety A patient profile consists of many independent metrics, recorded over a period of time. The ability to look at patient data and get quick insights into patient safety status across the duration of a study is imperative for detecting and addressing medical safety signals as soon as possible. As clinical trials progress, multiple data systems are often used to record and manage data. Fragmented information, listed in spreadsheets, an EDC platform, and other clinical software systems makes it more difficult to make quick determinations about patient safety. Siloed and ad hoc data also raises concerns about data quality, in terms of timeliness, completeness, and accuracy. By bringing all the necessary data in one place and establishing governance rules to ensure quality, medical monitors can generate visualizations that make it much easier to track the safety status of patients in a graphical patient profile, or GPP. When a GPP is designed efficiently and with patient safety and clinical data in mind, monitors can understand each patient’s status in a single view. Dashboards and data views can be customized and tailored to the roles and responsibilities of individuals or groups of users.

Transcript of Overview LSAC Graphical Patient Pro les (GPP)...SOLUTIO RIF LSAC Graphical Patient Pro les (GPP)...

Page 1: Overview LSAC Graphical Patient Pro les (GPP)...SOLUTIO RIF LSAC Graphical Patient Pro les (GPP) Overview Patient safety is a primary focus of medical monitoring during clinical trials.

SOLUTION BRIEF

LSAC Graphical Patient Profiles (GPP)

Overview

Patient safety is a primary focus of

medical monitoring during clinical

trials. Understanding the scientific and

medical parameters relevant to each

patient, however, can be challenging

when multiple software systems and

stakeholders are involved.

Saama’s Clinical Insights application,

part of the Life Science Analytics Cloud

(LSAC), offers a streamlined solution for

medical teams that need to stay on top

of all safety data requirements.

GPP’s Role in Facilitating Patient Safety

A patient profile consists of many independent metrics, recorded over a

period of time. The ability to look at patient data and get quick insights into

patient safety status across the duration of a study is imperative for detecting

and addressing medical safety signals as soon as possible.

As clinical trials progress, multiple data systems are often used to record

and manage data. Fragmented information, listed in spreadsheets, an EDC

platform, and other clinical software systems makes it more difficult to

make quick determinations about patient safety. Siloed and ad hoc data also

raises concerns about data quality, in terms of timeliness, completeness, and

accuracy.

By bringing all the necessary data in one place and establishing governance

rules to ensure quality, medical monitors can generate visualizations that

make it much easier to track the safety status of patients in a graphical

patient profile, or GPP.

When a GPP is designed efficiently and with patient safety and clinical data

in mind, monitors can understand each patient’s status in a single view.

Dashboards and data views can be customized and tailored to the roles and

responsibilities of individuals or groups of users.

Page 2: Overview LSAC Graphical Patient Pro les (GPP)...SOLUTIO RIF LSAC Graphical Patient Pro les (GPP) Overview Patient safety is a primary focus of medical monitoring during clinical trials.

SOLUTION BRIEF: LSAC Graphical Patient Profiles (GPP)

This panel gives you the

ability to filter subjects

individually or look at

groups of subjects from

a specific site or cohort.

Under the patient

information section.

You can see the patient’s entire history over the course of the study,

including Individual assessment results, exposure, and dosing

information drawn from EDC data, CTMS data, labs, and other

sources. Patient reactions are tracked and shown with respect to a

normal range that is clearly marked, and all data is presented in a

time-series format. Relevant medical or safety staff can take one look

at the dashboard and see if anything is outside the specified normal

range, which is marked by a horizontal blue bar.

Subject identifying information clearly listed.

Let’s take a look at a typical patient information visualization in LSAC.

With clear, color-coded visualization, users can also track AEs, understand their severity at a glance, and draw inferences about

their origins, such as whether they’re tied to the drug, a related AE, or to something else. To add additional context, users can

hover over a particular lab value or adverse event to see related analytics or listings.

Page 3: Overview LSAC Graphical Patient Pro les (GPP)...SOLUTIO RIF LSAC Graphical Patient Pro les (GPP) Overview Patient safety is a primary focus of medical monitoring during clinical trials.

[email protected]+1 888.205.3500

Saama and other marks used herein are trademarks of Saama Technologies, Inc Copyright © 2020 Saama Technologies, Inc

SOLUTION BRIEF: LSAC Graphical Patient Profiles (GPP)

About Saama Technologies, Inc. Saama is the #1 AI clinical analytics platform company, enabling the life sciences industry to conduct faster and safer clinical development and regulatory programs. Today, 50 biotech companies use Saama’s award-winning Life Science Analytics Cloud (LSAC) platform on over 1,500 studies, including many of the top 20 pharmaceutical companies. LSAC’s rich applications facilitate an unprecedented, authoritative oversight of comprehensive clinical research data, enabling companies to file New Drug Applications (NDAs) more efficiently and bring drugs to market faster. Discover more at www.saama.com and follow Saama @SaamaTechInc

LSAC GPP Provides the Ultimate Flexibility

With an advanced and highly configurable platform such as LSAC, users have the ability to apply various filters to patient data.

They can view specific types of data about a subject, allowing them to narrow their focus and stay on point with their roles and

responsibilities and not get distracted by other users’ data requirements. A site or study manager could also specify user access

to limit views and customize dashboards for specific teams and roles.

The LSAC GPP also allows users to drill down to details of any listing immediately, without having to run additional queries, pull

separate dashboards, or exit the current screen. This convenience is critical for busy managers who need to quickly determine

the safety status of patients across multiple sites. Using an AI-powered solution trained on clinical trial-related data sets can

significantly reduce the time to accurate, critical patient insights. All data remains coalesced and various users are able to

leverage it as per their need without getting sidetracked.

Medical teams leveraging Saama’s Clinical Insights application have always benefited from our approach of bringing data

together from multiple sources and harmonizing it so valuable insights can be leveraged. We are dedicated to ensuring that the

insights drawn from data are actionable and accurate.

To see other intuitive and powerful analytics for medical and safety teams, visit our Clinical Insights product page.